谷歌浏览器插件
订阅小程序
在清言上使用

The Effect of Prophylactic Carbapenem Use on Outcomes in Acute Pancreatitis: A Systematic Review and Meta-Analysis.

Merve Buyukkoruk, Ahmet Furkan Senturk,Hasan Selcuk Ozger

Infectious diseases and clinical microbiology(2023)

引用 0|浏览5
暂无评分
摘要
Objective: This study aimed to determine the effect of prophylactic use of carbapenems for acute pancreatitis on clinical outcomes. Materials and Methods: It was conducted according to the preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines by using the keywords "Pancrea* AND carbapenem OR imipenem OR ertapenem OR meropenem OR doripenem." Primer outcomes were mortality, surgical intervention, and pancreatic and non-pancreatic infection. Subgroup analyses were also performed to reduce the risk of bias. Results: Ten studies with 4038 patients were included in the meta-analyses. While eight of ten were randomized controlled trials, two were observational studies. The prophylactic use of carbapenems had no statistically significant effect on mortality (OR=0.82, 95% CI=0.65-1.04, I2=0%) and surgical intervention. (OR=0.81, 95% CI=0.57-1.17, I2=0%). However, the real impact of prophylaxis on reducing the incidence of mortality and surgical intervention was uncertain due to the insufficient sample size. The prophylactic use of carbapenems was sig-nificantly associated with a lower risk of peripancreatic (OR=0.37, 95% CI=0.25-0.55, I2=61%) and non-pancreatic infection risk (OR=0.60, 95% CI=0.46-0.78, I2=65%). The definitions of infection in the articles were not clear, and the diagnostic approach to infection was based on subjective criteria. In addition, there was inadequate collateral damage and safety as-sessments. In high-quality studies with a low risk of bias, prophylactic carbapenems had no effect on peripancreatic infection (RR=1.54, 95% CI=0.65-3.47, I2=0%) and non-pancreatic infection (RR=0.72, 95% CI=0.48-1.07, I2=0%). Conclusion: Although there is a reduction in the infection risk, routine carbapenem use in acute pancreatitis cases should not be recommended based on current evidence. Cooperation with Infectious Disease specialists and developing diagnostic algorithms are required instead of routine prophylaxis to prevent infection, especially non-pancreatic in-fection.
更多
查看译文
关键词
acute pancreatitis,necrotizing pancreatitis,carbapenem,prophylaxis,system-atic review,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要